ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,370.31
0.00%
Dow Jones
39,671.04
-0.51%
Gold vs US Dollar
2,365.31
-0.70%
Brent Oil
82.335
0.99%
Bitcoin
69,514.64
0.60%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Ayala Pharmaceuticals Inc (PK) (ADXS)

  7. Ayala Pharmaceuticals Inc (PK) (ADXS) News

Ayala Pharmaceuticals (PK) (ADXS)

Ayala Pharmaceuticals Inc (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:ADXS
DateTimeSourceHeadlineSymbolCompany
06/03/202412:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
05/03/202421:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
05/03/202413:16Edgar (US Regulatory)Form DEFM14C - Definitive information statement relating to merger or acquisitionUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
23/02/202421:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
20/02/202422:22Edgar (US Regulatory)Form PREM14C - Preliminary information statements relating to merger or acquisitionUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
14/02/202421:26Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
12/02/202419:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
12/02/202416:58Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
12/02/202413:27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
09/02/202422:15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
06/02/202413:51Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
03/01/202421:18Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
21/11/202314:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
21/11/202314:00Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
20/11/202314:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
15/11/202321:04Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
08/11/202321:01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
03/11/202315:46Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
03/11/202315:45Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
03/11/202315:43Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
02/11/202320:05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
31/10/202311:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
31/10/202311:05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
23/10/202311:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
23/10/202311:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
23/10/202311:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
23/10/202311:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
20/10/202321:31Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
29/09/202311:13Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
29/09/202311:10Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
 Showing the most relevant articles for your search:USOTC:ADXS

Your Recent History

LSE
50OW
Uruguay 28
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved